Chronic kidney injury in patients after cardiac catheterisation or percutaneous coronary intervention: a comparison of radial and femoral approaches (from the British Columbia Cardiac and Renal Registries)

被引:73
作者
Vuurmans, Tycho [1 ]
Byrne, Jonathan [2 ]
Fretz, Eric [1 ]
Janssen, Christian [3 ]
Hilton, J. David [1 ]
Klinke, W. Peter [1 ]
Djurdjev, Ognjenka [4 ]
Levin, Adeera [4 ]
机构
[1] Royal Jubilee Hosp, Div Intervent Cardiol, Victoria, BC, Canada
[2] Kings Coll London, London WC2R 2LS, England
[3] Univ Alberta, Edmonton, AB T6G 2M7, Canada
[4] Univ British Columbia, Div Nephrol, Vancouver, BC V5Z 1M9, Canada
关键词
CONTRAST-INDUCED NEPHROPATHY; LINE SERUM CREATININE; RISK-FACTORS; REQUIRING DIALYSIS; DIABETES-MELLITUS; DISEASE; OUTCOMES; ACCESS; MORTALITY; FAILURE;
D O I
10.1136/hrt.2009.192294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Acute kidney injury (AKI) is a well-recognised complication of cardiac catheterisation and percutaneous coronary intervention (PCI). However, the incidence of chronic kidney disease (CKD) after catheterisation and PCI has not been fully evaluated. A number of risk factors have been implicated in the development of AKI following cardiac catheterisation. Transradial access could lead to a lower incidence of CKD after catheterisation or PCI because of less catheter contact with aortic atheroma, and reduced potential for atheroembolism. Objective To determine the incidence of CKD onset and its association with arterial access in patients after cardiac catheterisation or PCI. Methods and results Linkages between the British Columbia (BC) Cardiac Registry (N-69 214) patients who underwent catheterisation or PCI between 1999 and 2005 and the BC Renal Database were determined. Within 6 months after the cardiac procedure 0.4% of patients developed dialysis dependency, 0.2% in the transradial versus 0.4% in the transfemoral group (p<0.0001); 0.3% of patients developed stage 4 or 5 CKD, 0.1% in the transradial versus 0.4% in the transfemoral group (p<0.0001); 0.9% of patients developed new CKD, 0.2% in the transradial versus 1.2% in the transfemoral group (p<0.0001). After adjusting for baseline characteristics the femoral access site had an OR of 4.36 (95% CI 2.48 to 7.66) for the development of the composite end point of new dialysis, new stage 4 or 5 CKD or new CKD. Conclusions In this large database of current practice coronary catheterisation and PCI, the incidence of CKD onset within 6 months of the procedure was 0.9%. The transradial access site is associated with less CKD than the femoral approach.
引用
收藏
页码:1538 / 1542
页数:5
相关论文
共 31 条
[1]   Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures - Systematic overview and meta-analysis of randomized trials [J].
Agostoni, P ;
Biondi-Zoccai, GGL ;
De Benedictis, ML ;
Rigattieri, S ;
Turri, M ;
Anselmi, M ;
Vassanelli, C ;
Zardini, P ;
Louvard, Y ;
Hamon, M .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (02) :349-356
[2]   Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification [J].
Bartholomew, BA ;
Harjai, KJ ;
Dukkipati, S ;
Boura, JA ;
Yerkey, MW ;
Glazier, S ;
Grines, CL ;
O'Neill, WW .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (12) :1515-1519
[3]   Serious renal dysfunction after percutaneous coronary interventions can be predicted [J].
Brown, Jeremiah R. ;
DeVries, James T. ;
Piper, Winthrop D. ;
Robb, John F. ;
Hearne, Michael J. ;
Lee, Peter M. Ver ;
Kellet, Mirle A. ;
Watkins, Mathew W. ;
Ryan, Thomas J. ;
Silver, M. Theodore ;
Ross, Cathy S. ;
MacKenzie, Todd A. ;
O'Connor, Gerald T. ;
Malenka, David J. .
AMERICAN HEART JOURNAL, 2008, 155 (02) :260-266
[4]   Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb/IIIa inhibition in acute myocardial infarction - the RADIAL-AMI pilot randomized trial [J].
Cantor, WJ ;
Puley, G ;
Natarajan, MK ;
Dzavik, V ;
Madan, M ;
Fry, A ;
Kim, HH ;
Velianou, JL ;
Pirani, N ;
Strauss, BH ;
Chisholm, RJ .
AMERICAN HEART JOURNAL, 2005, 150 (03) :543-549
[5]   Association of the arterial access site at angioplasty with transfusion and mortality: the MORTAL study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg) [J].
Chase, A. J. ;
Fretz, E. B. ;
Warburton, W. P. ;
Klinke, W. P. ;
Carere, R. G. ;
Pi, D. ;
Berry, B. ;
Hilton, J. D. .
HEART, 2008, 94 (08) :1019-1025
[6]   Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables [J].
Dangas, G ;
Iakovou, I ;
Nikolsky, E ;
Aymong, ED ;
Mintz, GS ;
Kipshidze, NN ;
Lansky, AJ ;
Moussa, I ;
Stone, GW ;
Moses, JW ;
Leon, MB ;
Mehran, R .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (01) :13-19
[7]   A population-based study of the incidence and outcomes of diagnosed chronic kidney disease [J].
Drey, N ;
Roderick, P ;
Mullee, M ;
Rogerson, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (04) :677-684
[8]  
DROST H, 1984, BRIT HEART J, V52, P339
[9]   Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose [J].
Freeman, RV ;
O'Donnell, M ;
Share, D ;
Meengs, WL ;
Kline-Rogers, E ;
Clark, VL ;
DeFranco, AC ;
Eagle, KA ;
McGinnity, JG ;
Patel, K ;
Maxwell-Eward, A ;
Bondie, D ;
Moscucci, M .
AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (10) :1068-1073
[10]   The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: A prospective study [J].
Fukumoto, Y ;
Tsutsui, H ;
Tsuchihashi, M ;
Masumoto, A ;
Takeshita, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :211-216